AAAAAA
Results:
1-10
|
Results: 10
Authors:
Yasasever, V
Ozcan, F
Camlica, H
Nane, I
Dalay, N
Citation: V. Yasasever et al., New urinary antigens as markers in bladder cancer, J TUMOR M, 16(2), 2001, pp. 147-152
Authors:
Tas, F
Aykan, F
Aydiner, A
Yasasever, V
Topuz, E
Citation: F. Tas et al., Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer, AM J CL ONC, 24(2), 2001, pp. 148-149
Authors:
Bitisik, O
Yavuz, S
Yasasever, V
Dalay, N
Citation: O. Bitisik et al., Telomerase activity in patients with chronic myeloid leukemia and lymphoma, RES COM M P, 107(1-2), 2000, pp. 3-12
Authors:
Tas, F
Aydiner, A
Topuz, E
Yasasever, V
Karadeniz, A
Saip, P
Citation: F. Tas et al., Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer, J EXP CL C, 19(4), 2000, pp. 477-481
Authors:
Yasasever, V
Dincer, M
Camlica, H
Duranyildiz, D
Dalay, N
Citation: V. Yasasever et al., Serum c-erb B2 oncoprotein levels are elevated in recurrent and metastaticbreast cancer, CLIN BIOCH, 33(4), 2000, pp. 315-317
Authors:
Yasasever, V
Meral, R
Camlica, H
Duranyildiz, D
Dalay, N
Citation: V. Yasasever et al., Serum NSE levels in the Turkish population, J TUMOR M, 14(3), 1999, pp. 35-40
Authors:
Yasasever, V
Oral, EN
Camlica, H
Dalay, N
Citation: V. Yasasever et al., CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer, J TUMOR M, 14(1), 1999, pp. 27-32
Authors:
Yasasever, V
Camlica, H
Oral, EN
Demokan, S
Dalay, N
Citation: V. Yasasever et al., Utility of CEA in the diagnosis of patients with cancer, J TUMOR M, 14(1), 1999, pp. 33-38
Authors:
Duranyildiz, D
Camlica, H
Yasasever, V
Ozcan, F
Dalay, N
Citation: D. Duranyildiz et al., Diagnostic value of the PSA subfractions, acid phosphatase and creatine kinase isoenzymes in prostate cancer, J TUMOR M, 14(1), 1999, pp. 39-46
Authors:
Inanc, SE
Meral, R
Darendeliler, E
Yasasever, V
Onat, H
Citation: Se. Inanc et al., Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors, ACTA ONCOL, 38(4), 1999, pp. 505-509
Risultati:
1-10
|